With a share of around one-third of the global IVD market, rapid tests conducted by patients or by healthcare professionals have revolutionized the diagnostics sector. The popularity of POCT is expected to surge further in future owing to faster results, technological advancements, and improving physicians’ demand for more efficient testing approaches, increased adoption of self-testing devices by patients, and availability of new biosensor technologies, and computer systems, resulting in a market worth US$ 24 Billion by 2018.